AXSM logo
Axsome Therapeutics, Inc.(AXSM)
Last print unknown agoAbout this dataData status
$155.81▼-1.33 (-0.85%)Stale · unknown oldEarnings · Nov 2

AXSM Operating Expenses

$912.58MTTM · USD

Period ending:

AXSM FY Operating ExpensesUSD
AXSM FY Operating Expenses2013-12-31: $1.84M2014-12-31: $5.67M2015-12-31: $9.20M2016-12-31: $27.54M2017-12-31: $27.16M2018-12-31: $32.85M2019-12-31: $67.11M2020-12-31: $99.14M2021-12-31: $124.71M2022-12-31: $224.64M2023-12-31: $476.36M2024-12-31: $632.95M2025-12-31: $760.25M$760.25M$0.00
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AXSM operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Axsome Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
760,253,000
632,952,000
476,360,000
224,638,000
124,707,000
99,141,328
67,105,649
32,846,577
27,164,307
27,543,508
9,196,276
5,672,030
1,839,438

Compare operating expenses

All AXSM financial metrics · AXSM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.